Pharmacy Podcast Network

Special Feature:    Andrew Crawford, Vice President at Keysource talks with TWIRx host Todd Eury about the direct to patient market (Direct to Consumer, DTC) expected to hit $21 billion this year. Pharmacy is evolving fast. When DTC brands move in, pharmacies have a choice...compete or collaborate. Some manufacturers are selling directly to patients at discounted cash prices and cutting out traditional intermediaries. The model is projected to grow 9% a year through 2030, with pharma support services expected to nearly double from $3.2B to $5.7B by 2030.  Driven by cost pressure and new legislation, manufacturers are moving quickly. It is creating more transparency but patients still need guidance, trust, and human care. Pharmacy is being redefined as the bridge that keeps care personal, safe, and local. It is not being replaced, but what will it look like in 10 years? TWIRx News:    Pharmacy student shot, killed by friend who became paranoid after they smoked pot together, documents say - from WMTV/Gray News  https://www.wowt.com/2025/11/11/pharmacy-student-shot-killed-by-friend-who-became-paranoid-after-they-smoked-pot-together-documents-say/  Why Guardian Pharmacy Services Stock Was on a Tear Tuesday - by Motley Fool / Yahoo Finance  https://finance.yahoo.com/news/why-guardian-pharmacy-services-stock-202435130.html Metformin May Diminish the Cardiometabolic Benefits of Exercise https://www.pharmacytimes.com/view/metformin-may-diminish-the-cardiometabolic-benefits-of-exercise Today's TWIRx is sponsored by YARAL Pharma & SureCost  

We hear from Ketan Mehta, CEO of PrimeRx.

Dr. Robert Popovian is a pharmacist, and economist with a deep background in research and public policy. In this episode we have a nuanced discussion on policy impacting pharmacy including PBMs, President Trumps Most Favored Nation Executive Order, Rebates, and insurance premiums.    Links to resources referenced in discussion: • Pioneer Institute, 340B tool: https://pioneerinstitute.org/340babuse/ • Pioneer Institute, IRA tool: https://pioneerinstitute.org/the-inflation-reduction-act-ira-overview/ • Editorial regarding TrumpRX: https://www.linkedin.com/pulse/promise-trumprx-robert-popovian-vskne/?trackingId=dtiG1P%2B%2BSDq6adLfFeEbeg%3D%3D • Pioneer Institute, IRA report: https://pioneerinstitute.org/wp-content/uploads/Prescription-Drug-Price-Controls-06252025.pdf  • GHLF tool, Impact of Accumulators and Maximizers on Premiums: https://cutt.ly/Rr9Di7Vf • Conquest Advisors website: https://conquestadvisors.godaddysites.com/

In this episode, host Todd Eury sits down with Terry Dean and Amanda Malooley to explore the growing importance of business intelligence in long-term care pharmacy. Together, they discuss the challenges pharmacies face in accessing and interpreting data, why real-time insight is becoming mission-critical, and how smarter visibility leads to better operational and clinical outcomes. The conversation then traces the journey behind FrameworkInsight—how it was envisioned, built, and continues to evolve to support pharmacy leaders in making informed, confident decisions.

Marketing Vitals host, Kelly Baily, is joined by Brian Prigge, President, CTO and Founder of GRX Marketing’s newest partner – Scriptly!  Learn more about this all-in-one, cloud-based, web-based pharmacy management system and see how your pharmacy can cut costs, streamline operations, and improve efficiency without sacrificing care. Visit scriptly.tech to learn more and schedule a free demo.

Welcome to the Pharmacy Podcast Network's coverage of the NCPA 2025 Post Show! The NCPA annual conference is the trailblazer for community pharmacy, bringing together the pharmacy community. Our host Todd Eury, founder and CEO of the Pharmacy Podcast Network, took the microphone to the action right on the show floor capturing exclusive conversations with attendees, pharmacy students, keynote speakers, vendors, and more!  Thank you RealValueRx for sponsoring this episode! realvaluerx.com   In this episode: JD Collier - RealValueRx  Rachel Matz - DocStation Johny Kello - MatchRx John DeJames  Stephanie Zimmerman - Real Value Rx; Jay Phipps Brad Gallagher - Barclay Damon LLP Scotty Sikes - Sikes and Co David Kirkus - PrimeRx Evan Walker - P3 Pharmacy Student

This Week in Pharmacy - November 7, 2025 TWIRx News: First up, Binghamton University School of Pharmacy holds emergency management simulation, VCU Health pharmacies expand access through new home delivery options, and Lilly and U.S. government agree to expand access to obesity medicines to millions of Americans.  Our special guest line up on TWIRx:   Amantha Bagdon - CEO of RxPost  PGX Pharmacist's Protection of Patients with Dr. Melissa Smith PharmD Arkansas HB 1150 TO PROHIBIT A PHARMACY BENEFITS MANAGER FROM OBTAINING CERTAIN PHARMACY PERMITS. with John Vinson CEO of the Arkansas Pharmacy Association & Greg Reybold with APCI  4th Generation Pharmacy Owner C.O. Bigelow (the oldest Apothecary in America) the Drugstore Cowboy, Alec Gingsberg PharmD Thank you toour sponsors:  Independent Pharmacy Cooperative (IPC) Yaral Pharma  SureCost The Drugstore Cowboy Rides Again: PBM Reform in Arkansas & PGx Safeguards for Xeloda Patients | TWIRx  

On this episode of MaternalRx on the Pharmacy Podcast Network, host Dr. Danielle Raiman Plummer, PharmD, consulting pharmacist, sits down with Mary Kucek, PMP, and Dr. Devin Bustin, MD, co-founders of OvaryIt, creators of the PRISM EHR platform and the OvaryIt Foundation for survivors of domestic abuse and human trafficking. Mary shares her powerful and life-threatening experience with a telemedicine platform that failed to follow contraceptive safety guidelines, an event that changed the course of her career and mission. Together, Mary and Dr. Bustin explain how their NIH-funded research led to the creation of OvaryIt and PRISM: an innovative, pharmacist-centered platform that bridges the safety of in-person care with the accessibility of telehealth. Tune in to hear how retail pharmacists can now lead the next evolution in family planning access, overcoming the barriers to scaling these services, and how technology and policy can empower safer, more equitable reproductive care for all. “Prism will help retail pharmacies become public health access points for central health services.”  💡 Stay Connected & Take Action! - Follow OvaryIt on all social platforms to stay updated on their mission to expand safe, pharmacist-led access to reproductive care. - For Patients: Learn more or find care at MyPrismHealth.com. - For Pharmacists, Pharmacy Owners, and Staff: Discover how to bring contraceptive care to your community with GetPrismRx.com. - Explore Free Education & Advocacy: Visit OvaryFund.org — the OvaryIt Foundation supporting survivors of domestic abuse and human trafficking through education and access. - Advocate for Change: Contact your local representatives to support the ECAPS Act, which recognizes pharmacists as healthcare providers under Medicare Part B and helps expand access to essential reproductive health services. Disclaimer: This podcast is for educational purposes only and should not replace medical advice. 🎧 Listen now to MaternalRx, redefining maternal health, from preconception through postpartum.

Fluoropyrimidines such as 5-fluorouracil (5-FU) and capecitabine remain cornerstone chemotherapies in oncology. However, for patients with certain DPYD gene variants, these commonly used drugs can cause life-threatening toxicities due to impaired metabolism of the active compounds. In this episode of the Precision Medicine Pharmacist Podcast, host Melissa Smith, PharmD, explores how DPYD genotyping is transforming oncology care by helping clinicians identify patients at risk before toxicity occurs. Joined by Karen Merritt, an advocate for universal DPD testing and leader with the Test4DPD initiative, the discussion sheds light on how pharmacogenomics is shaping safer, more personalized cancer treatment. Together, they explore current evidence, new FDA updates, and implementation frameworks that empower pharmacists and oncology teams to prevent preventable harm through precision medicine. 🧠 Key Discussion Topics The science behind DPYD gene variants and their clinical implications How undiagnosed DPD deficiency contributes to preventable toxicity New recommendations from the CPIC® Guideline for Fluoropyrimidines and DPYD Insights from the Guide for Implementing DPYD Genotyping for Systemic Fluoropyrimidines Advocacy for universal DPYD testing across oncology centers How pharmacists can champion pharmacogenomic testing integration in oncology workflows Updates from the FDA-approved labeling for Xeloda (capecitabine) 🎧 Featured Guest Karen Merritt LinkedIn Profile Karen Merritt is a passionate advocate for pharmacogenomic testing and patient safety in oncology care. Through her leadership in the Test4DPD movement, she works to expand awareness and adoption of DPYD testing worldwide, ensuring patients are protected from severe chemotherapy-related toxicities. 📚 Resources & References Guide for Implementing DPYD Genotyping for Systemic Fluoropyrimidines into Clinical Practice (PMC) CPIC® Guideline for Fluoropyrimidines and DPYD Advocates for Universal DPD/DPYD Testing – Test4DPD Updated FDA-Approved Label for Xeloda (Capecitabine)   💊 About the Show The Precision Medicine Pharmacist Podcast explores the evolving role of pharmacists in precision health, pharmacogenomics, and individualized patient care. Each episode highlights clinical insights, implementation strategies, and inspiring stories from professionals leading the way in personalized medicine.

During this episode of the NASP Podcast, Sheila Arquette, President & CEO of NASP, speaks with Sheri Wallace, Account Representative at AcariaHealth Specialty Pharmacy, and Diane Omdahl, RN, MS, founder of 65 Incorporated, published author and consultant on Medicare, to unpack the complexities of the Medicare Prescription Payment Plan (MPPP). Drawing on decades of patient access experience and the finer points of Medicare, they share insights on how these changes impact patients, providers, and pharmacies alike. Learn the importance of education, transparency, and advocacy in ensuring patients don’t fall through the cracks during these changes. Whether you're a provider, pharma partner, or patient advocate, this episode offers practical guidance and expert perspectives to help you navigate the evolving Medicare landscape.